Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FWSLW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,834
Award facts
- Contract value 100% obligated
- $12,834.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xeljanz XR 11 mg tablets in a quantity of 30-unit bottles. This is a firm fixed-price delivery order with a ceiling value of $12,834.49 and an ultimate completion date of August 5, 2025. The contract was competitively awarded with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle valued through December 2026 that provides comprehensive pharmaceutical support for military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal medical supply contracts serving defense and veteran healthcare systems. The company demonstrates significant capability in fulfilling competitive federal procurement requirements across a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies. As a critical vendor within the Defense Health Agency's supply chain, AmerisourceBergen continues to support military medical operations through delivery orders such as this one, contributing to the broader pharmaceutical prime vendor program supporting U.S. military and federal healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FWSLW?
SPE2DB25FWSLW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FWSLW worth?
The government has obligated $12,834 on SPE2DB25FWSLW.
Is contract SPE2DB25FWSLW an order under another contract?
Yes. SPE2DB25FWSLW is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB25FWSLW competed?
The extent of competition for SPE2DB25FWSLW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award